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Epidemiological studies, clinical observations and animal studies
demonstrate that non-steroidal anti-inflammatory drugs (NSAIDs)
can prevent colorectal cancer (reviewed in Shiff and Rigas, 1997;
Smalley and DuBois, 1997). However, the mechanism for reduc-
tion of colorectal cancer by NSAIDs is not completely understood.
Different mechanisms have been proposed, including inhibition of
cell proliferation, inhibition of carcinogen production, potentiation
of immune response, inhibition of angiogenesis and induction of
apoptosis (Shiff and Rigas, 1997; Tsujii et al, 1998). These mecha-
nisms are not exclusive and the effect of NSAIDs on the biology of
cancer cells may depend on a combination of them.
Apoptosis is critical for the control of colon epithelial cell
number (Hall et al, 1994). The evidence obtained in recent years
indicates that many cancer chemotherapy agents induce apoptosis
of tumour cells (Hannun, 1997). NSAIDs induce apoptosis of
different cell types, including human colorectal tumour cell lines
(Piazza et al, 1995; Shiff et al, 1995; Elder et al, 1996) and rat
enterocytes (Arber et al, 1997). Furthermore, administration of
NSAIDs induces apoptosis of colon cancer cells in vivo (Pasricha
et al, 1995; Boolbol et al, 1996). The mechanism responsible for
this apoptotic effect of NSAIDs is not clear. Aspirin and other
NSAIDs directly target cyclooxygenase (COX) (Vane, 1971), a
key enzyme in the production of prostaglandins, prostacyclins and
thomboxanes (Smith, 1989). Although COX is the molecular
target of most NSAIDs, both COX-dependent and COX-indepen-
dent mechanisms in the apoptotic action of NSAIDs have been
reported (Shiff and Rigas, 1997; Elder and Paraskeva, 1998; Gupta
and DuBois, 1998).
Whether or not aspirin induces apoptosis is still controversial. It
has been reported that aspirin, in contrast to other NSAIDs, does
not induce apoptosis either in colon carcinoma HT-29 cells (Shiff
et al, 1996; Piazza et al, 1997), or in v-src-transformed chicken
fibroblasts (Lu et al, 1995). However, we found that in B-CLL
cells aspirin induces all the typical features of apoptosis, including
internucleosomal DNA fragmentation, decrease in DNA content,
increase in phosphatidylserine exposure and proteolysis of
poly(ADPribose) polymerase (PARP) (Bellosillo et al, 1998).
Consistent with our results, it has been reported that aspirin
induces apoptosis of colon adenocarcinoma Caco-2 cells (Ricchi
et al, 1997), HT-29 cells (Qiao et al, 1998) and crypt cells (Barnes
et al, 1998). The apoptotic action of aspirin on B-CLL cells was
inhibited by the caspase inhibitor Z-VAD.fmk, demonstrating
the involvement of caspases (Bellosillo et al, 1998). Caspases are
responsible for many of the biochemical and morphological
processes during apoptosis, including DNA fragmentation, phos-
phatidylserine exposure, degradation of nuclear lamins, nuclear
morphological changes, and proteolysis of PARP and other
enzymes involved in DNA repair and genomic stability (Cohen,
1997; Cryns and Yuan, 1998).
In HT-29 cells, the cell death induced by aspirin was associated
neither with a ladder pattern in genomic DNA electrophoresis nor
with a subdiploid peak in flow cytometry, so it was considered
‘atypical apoptosis’ (Qiao et al, 1998). A very recent report
concludes that necrosis rather than apoptosis is the mechanism that
accounts for aspirin toxicity in human colon SW 620 and HT-29
cells (Subbegowda and Frommel et al, 1998).
Aspirin is one of the most widely studied NSAIDs in the
prevention of colon cancer. Thus, from the viewpoint of colon
cancer chemotherapy it is important to reveal the mechanism of
aspirin-induced cell death. Furthermore, for in vitro studies of
colon cancer chemotherapy-induced apoptosis, the human colonic
adenocarcinoma cell line HT-29 is a valuable tool. The aim of this
study was to further analyse the induction of cell death by aspirin
in HT-29 cells, focusing on the effect of aspirin on the activation of
caspases.
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Summary The induction of cell death by aspirin was analysed in HT-29 colon carcinoma cells. Aspirin induced two hallmarks of apoptosis:
nuclear chromatin condensation and increase in phosphatidylserine externalization. However, aspirin did not induce either oligonucleosomal
fragmentation of DNA, decrease in DNA content or nuclear fragmentation. The effect of aspirin on Annexin V binding was inhibited by the
caspase inhibitor Z-VAD.fmk, indicating the involvement of caspases in the apoptotic action of aspirin. However, aspirin did not induce
proteolysis of PARP, suggesting that aspirin does not increase nuclear caspase 3-like activity in HT-29 cells. This finding may be related with
the ‘atypical’ features of aspirin-induced apoptosis in HT-29 cells.
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MATERIALS AND METHODS
Reagents
Aspirin (acetylsalicylic acid), 3,(4,5-dimethylthiazol-2-yl)2,4-
diphenyltetrazolium bromide (MTT) and propidium iodide were
obtained from Sigma (St Louis, MO, USA). Fetal calf serum
(FCS) was from Gibco Laboratories and Dulbecco’s modified
Eagle’s medium (DMEM) was from Biological Industries. N-
benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl ketone (Z-
VAD.fmk) was obtained from Enzyme Systems Products (Dublin,
CA, USA). Annexin V-FITC was obtained from Boehinger
Ingelheim. PARP polyclonal antibody (Vi.5) raised against the
recombinant human PARP over-produced in Sf 9/baculovirus was
kindly provided by Dr Gilbert de Murcia (Strasbourg, France). All
the other reagents were of analytical grade.
Cell culture
The human colon adenocarcinoma cell line HT-29 (ATCC HTB
28) was obtained from the European Type Culture Collection.
Stock cultures of cells were maintained in DMEM supplemented
with 10% FCS, L-glutamine (2 mM), penicillin (100 units ml–1) and
streptomycin (100 mg ml–1) in a humidified atmosphere of 10%
carbon dioxide/90% air at 37°C. To obtain cultures for experi-
mental purposes, cells were plated at 25 000 or 50 000 cells cm–2.
Assays using preconfluent conditions were treated by adding the
appropriate amount of drug stock solution directly to the media in
absence of FCS the day after plating at the described densities.
Cell number assay
Cell number was determined by the MTT assay (Mosmann, 1983).
HT-29 cells (20 000 cells per well) were incubated in 24-well
plates in the absence or in the presence of factors in a final volume
of 500 ml. At different times, 50 ml of MTT (5 mg ml–1 in phos-
phate-buffered saline (PBS) was added to each well for a further
3 h. The blue MTT formazan precipitated was dissolved in 500 ml
of isopropanol: 1 M hydrochloric acid (24:1) and the absorbance
values at 570 nm were determined on a multiwell plate reader.
Apoptosis
In all experiments floating and freshly trypsinized cells were
pooled and apoptosis was evaluated by the following assays.
Measurement of the annexin-V and propidium iodide
staining by FACS analysis
Cells were washed twice in binding buffer (10 mM HEPES–
sodium hydroxide pH 7.4, 140 mM sodium chloride, 2.5 mM
calcium chloride, and resuspended in the same buffer at
106 cells ml–1 in the presence of 0.5 ml of annexin-V-FITC. After
30 min of incubation at room temperature, propidium iodine (PI)
was added at 0.05 mg ml–1. The fluorescence of cells was analysed
by flow cytometry (FACSCalibur, Becton Dickinson, Mountain
View, CA, USA), using the Cell Quest software.
Measurement of cell detachment
HT-29 cells (200 000 cells per well) were incubated in 35-mm
dishes in the absence or in the presence of factors in a final volume
of 2 ml. The total number of floating and attached cells was deter-
mined by microscopy using the Neubauer micro slide.
Western blot analysis of PARP
Cells were plated onto 100 cm2 dishes at a density of 5 ´ 106 cells
per dish. After washing the cultures with PBS, they were lysed
with Laemmli sample buffer (Laemmli, 1970) and samples were
incubated for 10 min at 100°C.
Protein concentration was determinated by the BCA Protein
Assay (Pierce, Rockford, IL, USA). Fifty micrograms of the
protein extract was subjected to sodium dodecyl sulphate poly-
acrylamide gel electrophoresis (SDS-PAGE), and transferred to
Immobilon-P membranes (Millipore, Bedford, MA, USA). After
blocking for 1 h with 5% dried skimmed milk in TBST (50 mM
Tris–HCl pH 8, 150 mM sodium chloride, 0.5% Tween-20), the
filters were incubated with Vi.2 antibody diluted 1:1000 in 5%
dried skimmed milk in TBST. Antibody binding was detected
by using a secondary antibody (anti-rabbit immunoglobulin,
Amersham, Buckinghamshire, UK) conjugated to horseradish
peroxidase diluted 1:5000 in 5% dried skimmed milk in TBST and
an enhanced chemiluminescence (ECL) detection kit (Amersham,
Buckinghamshire, UK).
Data analysis
All data points shown are mean values ± s.e.m. of n independent
experiments. The data points from duplicates or triplicates of an
individual experiments were averaged, and the data points shown
are the mean of these averages from n experiments. Statistical
significance of differences was assessed by ANOVA (Fisher PLSD
test). Differences between absence and presence of aspirin are
indicated by (*) P < 0.05, (**) P < 0.01 and (***) P < 0.001.
RESULTS
Cytotoxic effect of aspirin on HT-29 cells
We first studied the cytotoxic effect of aspirin on HT-29 cells. Cells
were incubated for 72 h with different aspirin concentrations,
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Figure 1 Cytotoxic effect of aspirin on HT-29 cells. (A) Dose–response of
the cytotoxic effect of aspirin on HT-29 cells. Cells were incubated for 72 h
with various concentrations of aspirin, ranging from 0 to 10 mM. Statistical
significance of differences was assessed between different concentrations of
aspirin vs control. Data are shown as the mean value ± SEM of five
independent experiments performed in triplicate. (B) Time-course of aspirin-
induced cytotoxicity on HT-29 cells. Cells were incubated without (l l) or with
10 mM aspirin (•) (ASA) for the times indicated. Statistical significance of
differences was assessed with respect to time zero. Cell viability was
determined by the MTT assay as described in Materials and Methods. The
results are expressed as a percentage of the optical density produced by the
starting number of cells. Data are shown as the mean value ± s.e.m. of six
independent experiments296 E Castaño et al
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ranging from 0 to 10 mM, and the number of viable cells was deter-
mined by the MTT assay. The decrease in cell number was dose-
dependent (Figure 1A). The mean IC50 of these dose–response
studies was 5 mM. In agreement with previous studies (Shiff et al,
1996; Qiao et al, 1998), aspirin treatment induced an increase in the
G0/G1 phase of the cell cycle (results not shown). As aspirin
inhibits proliferation, only a decrease in the number of cells with
respect to time zero necessarily implies an increase in cell death.
Thus, the cytotoxicity of aspirin on HT-29 cells was studied with
time-course assays. A significant increase in cell death was
observed after 48 h of incubation with 10 mM aspirin (Figure 1B).
Characterization of aspirin-induced cell death in HT-29
cells
We next studied the characteristics of aspirin-induced cell death in
HT-29 cells. The appearance of apoptotic cells was analysed in
treated cultures according to morphological criteria (Duke and
Cohen, 1992). The addition of aspirin to HT-29 cells induced
morphological changes characteristic of apoptosis, including cell
shrinkage and strong condensation of nuclei (data not shown).
However, nuclear fragmentation or apoptotic bodies were not
observed. Consistent with a previous report (Qiao et al, 1998),
cells treated with several concentrations of aspirin did not show
evidence of a ladder pattern of their genomic DNA when analysed
by agarose gel electrophoresis, nor a decrease in DNA content
when analysed by flow cytometry (data not shown).
To corroborate the induction of apoptosis by aspirin in HT-29
cells, the externalization of phosphatidylserine was studied with
the annexin V-binding assay (van Engeland et al, 1998). The
affinity of annexin V for the PS residues allows the percentage of
cells undergoing apoptosis to be quantified by flow cytometry.
Apoptotic and necrotic cells were distinguished on the basis of a
double-labelling for annexin V-FITC and PI, a membrane imper-
meable DNA stain. Aspirin induced a dose-dependent increase in
the percentage of apoptotic cells (annexin V-positive/PI-negative),
when treated for 24 h (Figure 2). In contrast, the number of
necrotic (annexin V-positive/PI-positive) and damaged (annexin
V-negative/PI-positive) cells was not significantly increased
(P > 0.05). At 48 h and 72 h an increase in the double positive
population was detected (Figure 2B). This effect is consistent with
the secondary necrosis process, which usually comes after apop-
tosis in cell cultures. These results demonstrate that aspirin
induces apoptosis of HT-29 cells.
Involvement of caspases in the apoptotic effect of
aspirin
We analysed whether incubation of HT-29 cells with aspirin
induced proteolytic cleavage of PARP, a hallmark of activation of
caspase-3 like proteases during apoptosis. Incubation of HT-29
cells for 72 h with various doses of aspirin, ranging from 2.5 to
10 mM, induced a decrease in the cellular levels of PARP without
detectable proteolysis (Figure 3). Proteolytic cleavage of PARP
was not detected at 24 h or at 48 h (data not shown). As positive
controls we used HT-29 cells treated with 1 mM staurosporine
(Figure 3) and aspirin-treated B-CLL cells (data not shown) which
revealed the 85 kDa fragment of PARP.
Apoptosis-induced PS exposure is prevented by caspase
inhibitors (Martin et al, 1996; Vanags et al, 1996). In order to
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Figure 2 Analysis of apoptosis by the annexin V binding assay. HT-29 cells
were treated with different concentrations of aspirin, which ranged from 0 to
10 mM. Annexin V binding was quantified as described in Materials and
Methods. (A) Representative dot plots of annexin V versus PI fluorescence
for control cells (a), and cells treated with 5 (b), 7.5 (c) and 10 mM (d) ASA
for 24 h. (B) Percentage of cells annexin V + / PI – (open bars), annexin V + /
PI + (dashed bars) and annexin V – / PI + (closed bars) after 24, 48 and 72 h
of treatment. Data shown are the mean values ± s.e.m. of two independent
experiments performed in duplicate
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Figure 3 Effect of aspirin on PARP cleavage. Cells were incubated for 72 h
with 0–10 mM aspirin (ASA) or 1 mM of staurosporin. PARP cleavage was
analysed on protein extracts from these cells by Western blot as described in
Materials and Methods. The position of native PARP (116 kDa) and the
proteolytic fragment (85 kDa) is indicatedAspirin-induced cell death in HT-29 cells 297
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assess the involvement of caspases in the apoptotic effect of
aspirin, we studied whether the caspase inhibitor Z-VAD.fmk
prevented aspirin-induced PS externalization. HT-29 cultures were
incubated for 24 h and 48 h with different concentrations of
aspirin in the presence or absence of 200 mM Z-VAD.fmk, which
had no cytotoxic effects. Z-VAD.fmk prevented the increase in
annexin+/IP2cells induced by aspirin at all concentrations used
(Figure 4A). Furthermore, Z-VAD.fmk also prevented aspirin-
induced cell detachment in HT-29 cells (Figure 4B).
DISCUSSION
The results shown in this report demonstrate that aspirin induces
caspase-dependent externalization of phosphatidylserine in HT-29
cells. It has been described that the loss of membrane asymmetry
during the apoptotic process results in the exposure of phospha-
tidylserine (PS) at the outer plasma membrane leaflet of the cell, a
fundamental characteristic that distinguishes apoptosis from
necrosis (reviewed in Van Engeland et al, 1998). This is a very
early phenomenon, which follows caspase activation but probably
precedes nuclear condensation. Aspirin-induced PS externaliza-
tion can be blocked by caspase inhibitors, demonstrating the
involvement of caspases. Furthermore, in agreement with previous
reports (Elder et al, 1996; Qiao et al, 1998), aspirin induced cell
detachment and morphological changes characteristic of apoptosis
in HT-29 cells. Considering these results, we can conclude that
aspirin induces an apoptotic process in HT-29 colonic carcinoma
cells. Although HT-29 cells express caspase-3, we did not detect
cleavage of PARP by caspase-3-like proteases during aspirin-
induced apoptosis in HT-29 cells. This finding could be related
with the ‘atypical’ apoptotic features of aspirin-induced cell death
in these cells. Some cell types from caspase-3 knockout mice are
incapable of DNA degradation, but display other hallmarks of
apoptosis, like PS externalization (Woo et al, 1998). Furthermore,
the MCF-7 breast carcinoma cell line, which does not express
caspase-3 (Janicke et al, 1998; Zapata et al, 1998), undergoes
apoptosis in the absence of DNA fragmentation (Oberhammer
et al, 1993; Janicke et al, 1998), but showing PS externalization
(Mangiarotti et al, 1998). Interestingly, MCF-7 cells treated with
the NSAID sulindac show nuclear condensation without clear
DNA ladder (Han et al, 1998).
The inability of aspirin to induce some of the biochemical char-
acteristics of apoptosis in HT-29 cells may be signal-specific,
since 7-hydroxystaurosporine (Shao et al, 1997), butyrate (Heerdt
et al, 1994), Fas (Bonnotte et al, 1998) and intestinal trefoil factor
3 (Efstathiou et al, 1998) induce oligonucleosomal fragmentation
of DNA in HT-29 cells. On the other hand, nitrogen mustard
induces apoptosis of HT-29 cells in the absence of DNA laddering
(Boddie et al, 1998).
The mechanisms by which NSAIDs induce apoptosis are not
clear. Consistent with the hypothesis that the apoptotic action of
NSAIDs is mediated by the inhibition of COX, overexpression of
COX-2 in rat epithelial intestinal cells inhibits butyrate-induced
apoptosis and this inhibition was reversed by the NSAID sulindac
sulphide (Tsujii and DuBois, 1995). However, the sulfone metabo-
lite of sulindac, which does not inhibit cyclooxygenases, also
induces apoptosis of HT-29 cells (Piazza et al, 1995), and COX-2
selective inhibitors induce apoptosis in human colorectal carci-
noma cell lines independently of COX-2 protein expression (Elder
et al, 1997). Taken together these results suggest the contribution
of COX-dependent and COX-independent mechanisms in the
apoptotic action of NSAIDs. Interestingly, we have recently
demonstrated that aspirin inhibits DNA synthesis in Swiss 3T3
fibroblasts by both COX-dependent and COX-independent mech-
anisms, depending on the concentration used (Castaño et al, 1997).
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Figure 4 Effect of the caspase inhibitor Z-VAD.fmk on aspirin-induced
apoptosis in HT-29 cells. (A) Effect of the caspase inhibitor Z-VAD.fmk on the
annexin-V binding of HT-29 cells. Cells were incubated for 24 or 48 h either
alone or in the presence of aspirin (ASA) (0, 7.5 or 10 mM) (open bars) or
aspirin with 200 mM Z-VAD.fmk (solid bars). Z-VAD.fmk was added 1 h prior
to aspirin administration. Annexin-V binding was quantified as described in
Materials and Methods. (B) Effect of the caspase inhibitor Z-VAD.fmk on cell
detachment. Cells were incubated for 48 h either alone or in the presence of
aspirin (ASA) (0, 7.5 or 10 mM) (open bars) or aspirin with 200 mM Z-VAD.fmk
(solid bars). Z-VAD.fmk was added 1 h before aspirin administration. The
data indicate the quantity of floating cells as a proportion of the total cell
number (attached and floating). Statistical significance of differences was
assessed between absence and presence of Z-VAD.fmk. Data are shown as
the mean value ± s.e.m. of three independent experiments made in triplicateCyclooxygenase-independent mechanisms have been impli-
cated in the inhibition of the transcription factor NF-kB by aspirin
and salicylate (Kopp and Ghosh, 1994; Schwenger et al, 1998).
Very recently, it has been reported that aspirin binds and inhibits
IkB kinase b (Yin et al, 1998). Remarkably, NF-kB has an essen-
tial role in preventing tumour necrosis factor a and cancer
therapy-induced apoptosis (Liu et al, 1996; Van Antwerp et al,
1996; Wang et al, 1996; Beg and Baltimore, 1996). The elucida-
tion of the mechanisms involved in the apoptotic action of aspirin
in HT-29 cells needs further investigation.
Many cancer cells demonstrate reduced capabilities of
responding to apoptotic stimuli (Hoffman and Liebermann, 1994).
The unusual features of aspirin-induced cell death in HT-29 cells
may offer clues to the mechanisms by which cancer cells escape
from apoptosis.
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